BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative productsfor inflammatory diseases and bone disorders, as well as medical devices for these same areas.
Investors
All regulatory information and reports.
Clinical studies
Learn more about clinical development and our ongoing studies.
Publication des résultats annuels 2024
Communication des résultats annuels 2024
Our technology
BioSenic aims to become a leading company in the field of regenerative and immune medicine by developing innovative products for inflammatory diseases and bone disorders.